Back to search
FDAFDA · Food and drugs·Recall number Z-0664-2017

Merge FlexConnect software, a component of Merge LIS. Merge FlexConnect is middleware used in conjunction with Merge LIS to facilitate connection to external applications

Published December 7, 2016 · Recall initiated: January 30, 2016

Summary

FDA records medical device Class II recall Z-0664-2017, published December 7, 2016 and initiated January 30, 2016. Recalling firm: Merge Healthcare, Inc.; Status: Terminated; Reported quantity: 324 sites potentially have the affected version; Lot: Version 1.0. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Communication protocols interfacing with the affected software version with some select instruments were not properly handled, preventing data captured by these instructions to be processed by the rest of the LIS software.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Merge Healthcare, Inc.
Distributor
Nationwide Distribution
Lot
Version 1.0
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Merge FlexConnect software, a component of Merge LIS. Merge FlexConnect is middleware used in conjunction with Merge LIS to facilitate connection to external applications recalled?

Yes. FDA published recall Z-0664-2017 on December 7, 2016. Reported hazard: Communication protocols interfacing with the affected software version with some select instruments were not properly handled, preventing data captured by these instructions to be processed by the rest of the LIS software.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit